403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Cardiol Therapeutics Inc.
(MENAFN- Baystreet) 09:40 AM EST - Cardiol Therapeutics Inc. : Announced today its year-end 2024 update on operations following the filing of its audited Financial Statements and Management's Discussion and Analysis for the year ended December 31, 2024. Both are available under the Company's profile on EDGAR at , on SEDAR+ at sedarplus and on the Company's website at cardiolrx. Cardiol Therapeutics Inc.
shares T are trading unchanged at $1.37.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Most popular stories
More Story
Comments
No comment